Xtl Biopharmaceuticals (XTLB) Income from Continuing Operations (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) recorded Income from Continuing Operations of -$0.90 in the year ended Dec 31, 2025, compared with $0.40 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Income from Continuing Operations (2009 - 2024) Analysis & Trends
Starting with the year ended Dec 31, 2009, Xtl Biopharmaceuticals' Income from Continuing Operations history includes 17 years.
- Annual Income from Continuing Operations has ranged from -$1.35 million in the year ended Dec 31, 2022 to $0.40 in the year ended Dec 31, 2024 over the past five years.
- Per Business Quant data, XTLB's Income from Continuing Operations was $0.40 in the year ended Dec 31, 2024, -$3.00 in the year ended Dec 31, 2023, -$1.35 million in the year ended Dec 31, 2022 and -$1.03 million in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Xtl Biopharmaceuticals | 2.27 Bn | 2.27 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 585,000.00 |
| Sep 30, 2024 | -764,000.00 |
| Jun 30, 2024 | -421,000.00 |
| Mar 31, 2024 | -175,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Sep 30, 2023 | -151,000.00 |
| Jun 30, 2023 | -163,000.00 |
| Mar 31, 2023 | -251,000.00 |
| Dec 31, 2022 | -225,000.00 |
| Sep 30, 2022 | -204,000.00 |
| Jun 30, 2022 | -202,000.00 |
| Mar 31, 2022 | -249,000.00 |
| Dec 31, 2021 | -286,000.00 |
| Sep 30, 2021 | -210,000.00 |
| Jun 30, 2021 | -303,000.00 |
| Mar 31, 2021 | 1.00 |
| Dec 31, 2020 | -2.00 |
| Sep 30, 2020 | -3.00 |
| Jun 30, 2020 | -1.00 |
| Dec 31, 2019 | -1.35 Mn |
API Access
Xtl Biopharmaceuticals Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();